Metabolic Diseases  >>  Lisofylline  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lisofylline / Islet Sci
NCT00464555: Strategies to Improve Islet Survival

Completed
2
5
US
Islet transplant, Antithymocyte globulin, Basiliximab, Lisofylline, Sirolimus, Tacrolimus
National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type 1 Diabetes Mellitus
11/11
02/14
NCT00896077: Subcutaneous Administration of Lisofylline to Healthy Normal Subjects and Subjects With Type 1 Diabetes

Completed
1/2
8
US
Lisofylline
DiaKine Therapeutics, Inc.
Healthy, Type 1 Diabetes
12/09
12/09
NCT01603121: Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus

Terminated
1/2
1
US
Lisofylline
Eastern Virginia Medical School
Type 1 Diabetes Mellitus
05/13
05/13

Download Options